January 9, 2018 / 9:21 PM / a month ago

Risperdal plaintiffs can seek punitive damages -Pennsylvania court

More than 6,400 patients in the litigation over Johnson & Johnson’s antipsychotic drug Risperdal will be able to make claims for punitive damages over allegations that the drug caused young men to develop breasts, a Pennsylvania state appeals court ruled on Monday.

In a unanimous decision, a two-judge panel of the Superior Court of Pennsylvania overturned a 2014 trial court decision that barred plaintiffs from asserting punitive damages in the mass tort over J&J’s and its Janssen Pharmaceuticals subsidiary alleged failure to warn of the risk of enlarged male breasts, a condition known as gynecomastia.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2FmsVZ8

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below